Mein Warenkorb

CD73

CD73 Molekülinformation

Englischer Name5'-nucleotidaseAnzahl der inverkehr gebrachten Arzneimittel0
Anzahl der klinischen Arzneimittel36Target-Alias5' Nucleotidase (CD73),5'-nucleotidase,5'-Nucleotidase, Ecto (CD73),Ecto-5'-nucleotidase,NT5E,5'-Nucleotidase Ecto,Ecto-5-Nucleotidase,5-NT,Purine 5-Prime-Nucleotidase,5-Nucleotidase, Ecto (CD73),5 Nucleotidase (CD73),5-Nucleotidase Ecto,5-Nucleotidase,CD73 Antigen,EC 3.1.3.5,CALJA,E5NT,ENT,NT,EN,CD73,5'-NT,NT5,NTE,EC:3.1.3.5
Höchste Forschungs- und EntwicklungsphasePhase 3 Clinical
Englischer Name5'-nucleotidase
Target-Alias5' Nucleotidase (CD73),5'-nucleotidase,5'-Nucleotidase, Ecto (CD73),Ecto-5'-nucleotidase,NT5E,5'-Nucleotidase Ecto,Ecto-5-Nucleotidase,5-NT,Purine 5-Prime-Nucleotidase,5-Nucleotidase, Ecto (CD73),5 Nucleotidase (CD73),5-Nucleotidase Ecto,5-Nucleotidase,CD73 Antigen,EC 3.1.3.5,CALJA,E5NT,ENT,NT,EN,CD73,5'-NT,NT5,NTE,EC:3.1.3.5
Anzahl der inverkehr gebrachten Arzneimittel0
Anzahl der klinischen Arzneimittel36
Höchste Forschungs- und EntwicklungsphasePhase 3 Clinical

CD73 Molekülalias

CD73,NT5E,5'-Nucleotidase,5'-NT,NT5,NTE

Klinische Arzneimittelinformation

Englischer NameForschungscodeForschungsphaseFirmaIndikationenKlinische Studie
UliledlimabTJD-5; TJ-004309; TJ-4309Phase 3 ClinicalI-Mab Biopharma Co LtdCarcinoma, Non-Small-Cell Lung; Carcinoma, Ovarian Epithelial; Gastrointestinal Neoplasms; Head and Neck Neoplasms; Neoplasm Metastasis; Ovarian Neoplasms; Solid tumours; Triple Negative Breast Neoplasms
Details
QuemliclustatAB-680Phase 3 ClinicalArcus Biosciences IncAdenocarcinoma; Bile Duct Neoplasms; Biliary Tract Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Pancreatic Ductal; Cholangiocarcinoma; Colorectal Neoplasms; Hormone-Resistant Prostate Neoplasms; Pancreatic Neoplasms; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant
Details
OleclumabMEDI-9447Phase 3 ClinicalMedimmune LlcAdenocarcinoma; Carcinoma; Carcinoma, Non-Small-Cell Lung; Carcinoma, Ovarian Epithelial; Carcinoma, Pancreatic Ductal; Carcinoma, Renal Cell; Colorectal Neoplasms; Fallopian Tube Neoplasms; Hemangiosarcoma; Liposarcoma; Osteosarcoma; Ovarian Neoplasms; Pancreatic Neoplasms; Peritoneal Neoplasms; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Solid tumours; Squamous Cell Carcinoma of Head and Neck; Triple Negative Breast Neoplasms; Urinary Bladder Neoplasms
Details
Dalutrafusp alfaGS-1423; AGEN-1423Phase 2 ClinicalAgenus IncCarcinoma, Pancreatic Ductal; Colorectal Neoplasms; Liver Neoplasms; Pancreatic Neoplasms; Solid tumours
Details
BMS-986179BMS-986179Phase 2 ClinicalBristol-Myers Squibb CompanySolid tumours
Details
MupadolimabCPX-006; COR-004 (Corvus Pharmaceuticals); CPI-006Phase 2 ClinicalCorvus Pharmaceuticals IncCarcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Colorectal Neoplasms; Coronavirus Disease 2019 (COVID-19); Endometrial Neoplasms; Head and Neck Neoplasms; Lymphoma, Non-Hodgkin; Ovarian Neoplasms; Pancreatic Neoplasms; Papillomavirus Infections; Prostatic Neoplasms, Castration-Resistant; Sarcoma; Solid tumours; Squamous Cell Carcinoma of Head and Neck; Triple Negative Breast Neoplasms; Urinary Bladder Neoplasms; Uterine Cervical Neoplasms
Details
XW-LTH-03XW-LTH-03Phase 2 ClinicalShanghai SinoBay Biotechnology Co LtdStomach Neoplasms
Details
CD73/AXL.HypoSti.CAR-T cells therapy (Pla General Hospital)Phase 2 ClinicalPla General HospitalSolid tumours
Details
DresbuxelimabAK-119Phase 2 ClinicalCarcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Coronavirus Disease 2019 (COVID-19); Idiopathic Pulmonary Fibrosis; Solid tumours
Details
GI-108GI-108Phase 2 ClinicalGI Innovation IncCarcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Neoplasms; Pancreatic Neoplasms; Solid tumours; Squamous Cell Carcinoma of Head and Neck
Details
S-095024S-095024; S095024Phase 2 ClinicalInstitut De Recherches Internationales Servier, Regeneron Pharmaceuticals Inc, Servier Bio-Innovation LLCCarcinoma, Non-Small-Cell Lung
Details
HB-0052HB0052; HB-0052Phase 2 ClinicalShanghai Huaota Biopharmaceutical Co Ltd, Zhejiang Huahai Pharmaceutical Co LtdPancreatic Neoplasms; Solid tumours
Details
HB-0045HB-0045; HB0045Phase 2 ClinicalHuaBo Biopharm Co Ltd, Shanghai Huaota Biopharmaceutical Co LtdSolid tumours
Details
JAB-BX102JAB-BX102Phase 2 ClinicalJacobio Pharmaceuticals Co LtdSolid tumours
Details
PT-199PT-199Phase 2 ClinicalPhanes Therapeutics IncCarcinoma, Non-Small-Cell Lung; Carcinoma, Pancreatic Ductal; Solid tumours
Details
LY-3475070LY-3475070Phase 1 ClinicalEli Lilly And CompanyNeoplasms
Details
Anti-CD73 monoclonal antibody (Bristol-Myers Squibb)Phase 1 ClinicalBristol-Myers Squibb CompanyNeoplasms
Details
AP-601AP-601Phase 1 ClinicalAP Biosciences IncNeoplasms; Solid tumours
Details
68Ga-dPNE68Ga-dPNEPhase 1 ClinicalFirst Affiliated Hospital Of Fujian Medical UniversityNeoplasms
Details
AK-137AK137; AK-137Phase 1 ClinicalNeoplasms
Details
68GA-DOTA-dPNE68GA-DOTA-dPNEPhase 1 ClinicalPeking Union Medical College HospitalBreast Neoplasms
Details
LNF-2008LNF-2008; LNF2008Phase 1 ClinicalShandong New Time Pharmaceutical Co LtdSolid tumours
Details
HB-0046HB0046; HB-0046Phase 1 ClinicalHuaBo Biopharm Co Ltd, Shanghai Huaota Biopharmaceutical Co LtdSolid tumours
Details
SYS-6011SYS6011; SYS-6011Phase 1 ClinicalJushi Biopharmaceutical Co LtdSolid tumours
Details
BPI-472372BPI-472372Phase 1 ClinicalBetta Pharmaceuticals Co LtdSolid tumours
Details
BB-1709BB-1709Phase 1 ClinicalBliss Biopharmaceutical (Hangzhou) Co LtdSolid tumours
Details
PM-1015PM1015; PM-1015Phase 1 ClinicalSolid tumours
Details
AK-131AK-131Phase 1 ClinicalNeoplasms; Solid tumours
Details
IBI-325IBI-325Phase 1 ClinicalSolid tumours
Details
BR-101BR101; BR-101Phase 1 ClinicalZhejiang BioRay Biopharmaceuticals Co LtdSolid tumours
Details
CB-708ATG-037; ATN-037; CB-708; CB708Phase 1 ClinicalCalithera Biosciences IncCarcinoma, Non-Small-Cell Lung; Melanoma; Neoplasms; Solid tumours
Details
HLX-23HLX-23Phase 1 ClinicalLymphoma; Solid tumours
Details
ORIC533ORIC-533Phase 1 ClinicalOric Pharmaceuticals IncMultiple Myeloma; Neoplasm Metastasis
Details
IPH-5301IPH-5301Phase 1 ClinicalInnate PharmaBreast Neoplasms; Endometrial Neoplasms; Esophageal Neoplasms; Lung Neoplasms; Metastatic breast cancer; Neoplasm Metastasis; Neoplasms; Pancreatic Neoplasms; Solid tumours; Stomach Neoplasms
Details
HBM-1007HBM1007; R 1007; HBM 1007; HBM-1007Phase 1 ClinicalHarbour BiomedNeoplasms; Solid tumours
Details
ABSK-051ABSK051Phase 1 ClinicalABbisko Therapeutics Co LtdNeoplasms; Solid tumours
Details

Produktrezensionen

  • H***g2021-11-29
    0Menschen mögen
    It was used in research of investgational new drugs. Specifically, I have used this product in my Epitope binning experiments (using Octet) and I am truely satisfied with the results. With this experiment and your product, we have found a approximate epitope binding site. Thanks for your highly qualified product.
  • Molekülinformation
  • Produktliste
  • Produktrezensionen
  • Klinische Arzneimittelinformation
Kontaktieren Sie uns